共找到 20 条结果
Innate immunity now occupies a central role in immunology. However, artificial immune system models have largely been inspired by adaptive not innate immunity. This paper reviews the biological principles and properties of innate immunity and, adopting a conceptual framework, asks how these can be incorporated into artificial models. The aim is to outline a meta-framework for models of innate immunity.
Immunity is hypothesized to share limited resources with other physiological functions and may mediate life history trade-offs, for example between reproduction and survival. However, vertebrate immune defense is a complex system that consists of three components. To date, no study has assessed all of these components for the same animal model and within a given situation. Previous studies have determined that the acquired immunity of common eiders (Somateria mollissima) is suppressed during incubation. The present paper aims to assess the innate immune response in fasting eiders in relation to their initial body condition. Innate immunity was assessed by measuring plasma nitric oxide (NO) levels, prior to and after injection of lipopolysaccharides (LPS), a method which is easily applicable to many wild animals. Body condition index and corticosterone levels were subsequently determined as indicators of body condition and stress level prior to LPS injection. The innate immune response in eiders did not vary significantly throughout the incubation period. The innate immune response of eiders did not vary significantly in relation to their initial body condition but decreased signifi
Currently, there are two major theories for the pathogenesis of sepsis: hyperimmune and hypoimmune. Hyperimmune theory suggests that cytokine storm causes the symptoms of sepsis. On the contrary, hypoimmune theory suggests that immunosuppression causes the manifestations of sepsis. By using microarray study, this study implies that hyperactivity of TH17-like innate immunity and failure of adaptive immunity are noted in sepsis patients. I find out that innate immunity related genes are significantly up-regulated including CD14, TLR1,2,4,5,8, HSP70, CEBP proteins, AP1(JUNB, FOSL2), TGF-β, IL-6, TGF-α, CSF2 receptor, TNFRSF1A, S100A binding proteins, CCR2, formyl peptide receptor2, amyloid proteins, pentraxin, defensins, CLEC5A, whole complement machinery, CPD, NCF, MMP, neutrophil elastase, caspases, IgG and IgA Fc receptors(CD64, CD32), ALOX5, PTGS, LTB4R, LTA4H, and ICAM1. Majority of adaptive immunity genes are down-regulated including MHC related genes, TCR genes, granzymes/perforin, CD40, CD8, CD3, TCR signaling, BCR signaling, T & B cell specific transcription factors, NK killer receptors, and TH17 helper specific transcription factors(STAT3, RORA, REL). In addition, Treg r
In a previous paper the authors argued the case for incorporating ideas from innate immunity into articficial immune systems (AISs) and presented an outline for a conceptual framework for such systems. A number of key general properties observed in the biological innate and adaptive immune systems were hughlighted, and how such properties might be instantiated in artificial systems was discussed in detail. The next logical step is to take these ideas and build a software system with which AISs with these properties can be implemented and experimentally evaluated. This paper reports on the results of that step - the libtissue system.
In a previous paper the authors argued the case for incorporating ideas from innate immunity into artificial immune systems (AISs) and presented an outline for a conceptual framework for such systems. A number of key general properties observed in the biological innate and adaptive immune systems were highlighted, and how such properties might be instantiated in artificial systems was discussed in detail. The next logical step is to take these ideas and build a software system with which AISs with these properties can be implemented and experimentally evaluated. This paper reports on the results of that step - the libtissue system.
Waning immunity and reinfection are critical features of many infectious diseases, but epidemiological models often fail to capture the intricate interaction between an individual's history of immunity and their current infection status; when they do, the approach is usually overly simplistic. We develop a novel dual-age structured model that simultaneously tracks immunity age (time since the last recovery from infection) and infection age (time since infection) to analyze epidemic dynamics under conditions of waning immunity and reinfection. The model is formulated as a system of age-structured partial differential equations that describe susceptible and infected populations stratified by both immunity and infection ages. We derive basic reproduction numbers associated with the model and numerically solve the system using a second-order Runge-Kutta scheme along the characteristic lines. We further extend the model to explore vaccination interventions, specifically targeting individuals according to their immunity age. Numerical results reveal that higher contact rates produce larger amplitude oscillations with longer interepidemic periods. The relationship between initial infectio
Diffusion processes pervade numerous areas of AI, abstractly modeling the dynamics of exchanging, oftentimes volatile, information in networks. A central question is how long the information remains in the network, known as survival time. For the commonly studied SIS process, the expected survival time is at least super-polynomial in the network size already on star graphs, for a wide range of parameters. In contrast, the expected survival time of the SIRS process, which introduces temporary immunity, is always at most polynomial on stars and only known to be super-polynomial for far denser networks, such as expanders. However, this result relies on featuring full temporary immunity, which is not always present in actual processes. We introduce the cSIRS process, which incorporates gradually declining immunity such that the expected immunity at each point in time is identical to that of the SIRS process. We study the survival time of the cSIRS process rigorously on star graphs and expanders and show that its expected survival time is very similar to that of the SIS process, which features no immunity. This suggests that featuring gradually declining immunity is almost as having non
Vaccination policies play a central role in public health interventions and models are often used to assess the effectiveness of these policies. Many vaccines are leaky, in which case the observed vaccine effectiveness depends on the force of infection. Within models, the immunity parameters required for agent-based models to achieve observed vaccine effectiveness values are further influenced by model features such as its transmission algorithm, contact network structure, and approach to simulating vaccination. We present a method for determining parameters in agent-based models such that a set of target immunity values is achieved. We construct a dataset of desired population-level immunity values against various disease outcomes considering both vaccination and prior infection from COVID-19. This dataset incorporates immunological data, data collection methodologies, immunity models, and biological insights. We then describe how we choose minimal parameters for continuous waning immunity curves that result in those target values being realized in simulations. We use simulations of the household secondary attack rates to establish a relationship between the protection per infecti
The bulk of the literature on opinion optimization in social networks adopts the Friedkin-Johnsen (FJ) opinion dynamics model, in which the innate opinions of all nodes are known: this is an unrealistic assumption. In this paper, we study opinion optimization under the FJ model without the full knowledge of innate opinions. Specifically, we borrow from the literature a series of objective functions, aimed at minimizing polarization and/or disagreement, and we tackle the budgeted optimization problem, where we can query the innate opinions of only a limited number of nodes. Given the complexity of our problem, we propose a framework based on three steps: (1) select the limited number of nodes we query, (2) reconstruct the innate opinions of all nodes based on those queried, and (3) optimize the objective function with the reconstructed opinions. For each step of the framework, we present and systematically evaluate several effective strategies. A key contribution of our work is a rigorous error propagation analysis that quantifies how reconstruction errors in innate opinions impact the quality of the final solutions. Our experiments on various synthetic and real-world datasets show
Herd immunity is a critical concept in epidemiology, describing a threshold at which a sufficient proportion of a population is immune, either through infection or vaccination, thereby preventing sustained transmission of a pathogen. In the classic Susceptible-Infectious-Recovered (SIR) model, which has been widely used to study infectious disease dynamics, the achievement of herd immunity depends on key parameters, including the transmission rate ($β$) and the recovery rate ($γ$), where $γ$ represents the inverse of the mean infectious period. While the transmission rate has received substantial attention, recent studies have underscored the significant role of $γ$ in determining the timing and sustainability of herd immunity. Additionally, it is becoming increasingly evident that assuming $γ$ as a constant parameter might oversimplify the dynamics, as variations in recovery times can reflect diverse biological, social, and healthcare-related factors. In this paper, we investigate how heterogeneity in the recovery rate affects herd immunity. We show empirically that the mean of the recovery rate is not a reliable metric for determining the achievement of herd immunity. Furthermore
SIRS epidemic models assume that individual immunity (from infection and vaccination) wanes in one big leap, from complete immunity to complete susceptibility. For many diseases immunity on the contrary wanes gradually, something that's become even more evident during COVID-19 pandemic where also recently infected have a reinfection risk, and where booster vaccines are given to increase immunity. This paper considers an epidemic model allowing for such gradual waning of immunity (either linear or exponential waning) thereby extending SIRS epidemics, and also incorporates vaccination. The two versions for gradual waning of immunity are compared with the classic SIRS epidemic, where the three models are calibrated by having the same \emph{average cumulative immunity}. All models are shown to have identical basic reproduction number $R_0$. However, if no prevention is put in place, the exponential waning model has highest prevalence and the classic SIRS model has lowest. Similarly, the amount of vaccine supply needed to reach and maintain herd immunity is highest for the model with exponential decay of immunity and lowest for the classic SIRS model. consequently, if truth lies close t
When a fraction of a population becomes immune to an infectious disease, the population-wide infection risk decreases nonlinearly due to collective protection, known as herd immunity. Some studies based on mean-field models suggest that natural infection in a heterogeneous population may induce herd immunity more efficiently than homogeneous immunization. However, we theoretically show that this is not necessarily the case when the population is modeled as a network instead of using the mean-field approach. We identify two competing mechanisms driving disease-induced herd immunity in networks: the biased distribution of immunity toward socially active individuals enhances herd immunity, while the topological localization of immune individuals weakens it. The effect of localization is stronger in networks embedded in a low-dimensional space, which can make disease-induced immunity less effective than random immunization. Our results highlight the role of networks in shaping herd immunity and call for a careful examination of model predictions that inform public health policies.
This work is devoted to the study of the probability of immunity, i.e. the effect occurs whether exposed or not. We derive necessary and sufficient conditions for non-immunity and $ε$-bounded immunity, i.e. the probability of immunity is zero and $ε$-bounded, respectively. The former allows us to estimate the probability of benefit (i.e., the effect occurs if and only if exposed) from a randomized controlled trial, and the latter allows us to produce bounds of the probability of benefit that are tighter than the existing ones. We also introduce the concept of indirect immunity (i.e., through a mediator) and repeat our previous analysis for it. Finally, we propose a method for sensitivity analysis of the probability of immunity under unmeasured confounding.
We introduce a two-strain model with asymmetric temporary immunity periods and partial cross-immunity. We derive explicit conditions for competitive exclusion and coexistence of the strains depending on the strain-specific basic reproduction numbers, temporary immunity periods, and degree of cross-immunity. The results of our bifurcation analysis suggest that, even when two strains share similar basic reproduction numbers and other epidemiological parameters, a disparity in temporary immunity periods and partial or complete cross-immunity can provide a significant competitive advantage. To analyze the dynamics, we introduce a quasi-steady state reduced model which assumes the original strain remains at its endemic steady state. We completely analyze the resulting reduced planar hybrid switching system using linear stability analysis, planar phase-plane analysis, and the Bendixson-Dulac criterion. We validate both the full and reduced models with COVID-19 incidence data, focusing on the Delta (B.1.617.2), Omicron (B.1.1.529), and Kraken (XBB.1.5) variants. These numerical studies suggest that, while early novel strains of COVID-19 had a tendency toward dramatic takeovers and extinct
We analyse an extended SIRS epidemic model in which immunity at the individual level wanes gradually at exponential rate, but where the waning rate may differ between individuals, for instance as an effect of differences in immune systems. The model also includes vaccination schemes aimed to reach and maintain herd immunity. We consider both the informed situation where the individual waning parameters are known, thus allowing selection of vaccinees being based on both time since last vaccination as well as on the individual waning rate, and the more likely uninformed situation where individual waning parameters are unobserved, thus only allowing vaccination schemes to depend on time since last vaccination. The optimal vaccination policies for both the informed and uniformed heterogeneous situation are derived and compared with the homogeneous waning model (meaning all individuals have the same immunity waning rate), as well as to the classic SIRS model where immunity at the individual level drops from complete immunity to complete susceptibility in one leap. It is shown that the classic SIRS model requires least vaccines, followed by the SIRS with homogeneous gradual waning, follo
Innate values describe agents' intrinsic motivations, which reflect their inherent interests and preferences for pursuing goals and drive them to develop diverse skills that satisfy their various needs. Traditional reinforcement learning (RL) is learning from interaction based on the feedback rewards of the environment. However, in real scenarios, the rewards are generated by agents' innate value systems, which differ vastly from individuals based on their needs and requirements. In other words, considering the AI agent as a self-organizing system, developing its awareness through balancing internal and external utilities based on its needs in different tasks is a crucial problem for individuals learning to support others and integrate community with safety and harmony in the long term. To address this gap, we propose a new RL model termed innate-values-driven RL (IVRL) based on combined motivations' models and expected utility theory to mimic its complex behaviors in the evolution through decision-making and learning. Then, we introduce two IVRL-based models: IV-DQN and IV-A2C. By comparing them with benchmark algorithms such as DQN, DDQN, A2C, and PPO in the Role-Playing Game (RP
Despite high vaccine coverage, pertussis has re-emerged as a public health concern in many countries. One hypothesis posed for re-emergence is the waning of immunity. In some disease systems, the process of waning immunity can be non-linear, involving a complex relationship between the duration of immunity and subsequent boosting of immunity through asymptomatic re-exposure. We present and analyse a model of infectious disease transmission to examine the interplay between infection and immunity. By allowing the duration of infection-acquired immunity to differ from that of vaccine-acquired immunity, we explore the impact of the difference in durations on long-term disease patterns and prevalence of infection. Our model demonstrates that vaccination may induce cyclic behaviour, and its ability to reduce the infection prevalence increases with both the duration of infection-acquired immunity and duration of vaccine-acquired immunity. We find that increasing vaccine coverage, while capable of leading to an increase in overall transmission, always results in a reduction in prevalence of primary infections, with epidemic cycles characterised by a longer interepidemic period and taller p
We adapt the article of Forien, Pang, Pardoux and Zotsa: Arxiv preprint Arxiv2210.04667(2022), on epidemic models with varying infectivity and waning immunity, to incorporate the memory of the last infection. To this end, we introduce a parametric approach and consider a piecewise deterministic Markov process modeling both the evolution of the parameter, also called the trait, and the age of infection of individuals over time. At each new infection, a new trait is randomly chosen for the infected individual according to a Markov kernel, and their age is reset to zero. In the large population limit, we derive a partial differential equation (PDE) that describes the density of traits and ages. The main goal is to study the conditions under which endemic equilibria exist for the deterministic PDE model and to establish an endemicity threshold that depends on the model parameters. The local stability of these equilibria is also analyzed. The endemicity threshold is computed for several examples, including models that incorporate a vaccination policy, and a local stability result is obtained for a memory-free SIS-type model.
Deepfakes pose an evolving threat to cybersecurity, which calls for the development of automated countermeasures. While considerable forensic research has been devoted to the detection and localisation of deepfakes, solutions for reversing fake to real are yet to be developed. In this study, we introduce cyber vaccination for conferring immunity to deepfakes. Analogous to biological vaccination that injects antigens to induce immunity prior to infection by an actual pathogen, cyber vaccination simulates deepfakes and performs adversarial training to build a defensive immune system. Aiming at building up attack-agnostic immunity with limited computational resources, we propose to simulate various deepfakes with one single overpowered attack: face masking. The proposed immune system consists of a vaccinator for inducing immunity and a neutraliser for recovering facial content. Experimental evaluations demonstrate effective immunity to face replacement, face reenactment and various types of corruptions.
Herd immunity is shaped not only by the infection capacity of a spreading epidemic or the contact structure of the hosting population, but also by how and under what circumstances individuals acquire immunity. Immunization strategies may interact with ongoing non-pharmaceutical interventions, which commonly aim to reduce social contact numbers. We demonstrate that these interactions can induce unexpectedly strong and counterintuitive effects on herd immunity. We explore these phenomena on spatially embedded contact networks and uncover a reversal in the relative effectiveness of disease- versus vaccine-induced immunization schemes, highlighting the average number of contacts as a critical determinant of emerging herd immunity. In sparse geometric networks with limited degree heterogeneity, uniform vaccination proves most effective; however, as average contact numbers increase, naturally acquired immunity ultimately becomes the better strategy. We show that this phenomenon may emerge not only in synthetic networks but also in real-world mixing networks, observed during non-pharmaceutical intervention periods across multiple states of the United States.